Skip to main content
Clinical Trials/NCT05198713
NCT05198713CompletedNot Applicable

Evaluation of Hearing Aid Benefit

Sonova AG2 sites in 1 country15 target enrollmentStarted: January 18, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Sonova AG
Enrollment
15
Locations
2
Primary Endpoint
Speech Intelligibility in Quiet.

Study Overview

Brief Summary

The present study will investigate the benefit of hearing aids for speech intelligibility (in both quiet and noisy environments) compared to the unaided condition. Participants will include adults with moderate to moderately severe hearing impairment. The participants will complete laboratory-based speech intelligibility assessments with binaural hearing aids and without hearing aids.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Moderate to moderately severe sensorineural hearing loss
  • Willingness to wear custom hearing instruments during the study.
  • Age-normal cognition
  • Ability to attend on-site study visits.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Speech Intelligibility in Quiet.

Time Frame: Day 1 and Day 15

Speech intelligibility for monosyllabic words presented in quiet. The words are presented at a fixed level and the percentage of words correctly repeated is calculated. A higher percentage is better. This was done in both unaided and aided conditions.

Secondary Outcomes

  • Speech Intelligibility in Noise, Expressed as the Signal to Noise Ratio at Which Participant Can Correctly Repeat 50% of the Words(Day 1 and Day 15)

Investigators

Sponsor
Sonova AG
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials